Cargando…
A gain-of-function CCR4 mutations in adult T-cell leukemia/lymphoma (ATL) enhance the chemotactic abilities and P13K/AKT activation
Autores principales: | Nakagawa, Masao, Schmitz, Roland, Xiao, Wenming, Yang, Yandan, Waldmann, Thomas A, Staudt, Louis M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578791/ http://dx.doi.org/10.1186/1742-4690-12-S1-O31 |
Ejemplares similares
-
Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma
por: Nakagawa, Masao, et al.
Publicado: (2014) -
Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014) -
Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011) -
Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015) -
High resolution lectin microarray system for the ATL cell-typing and the evaluation of anti-cancer efficacy of medications
por: Iha, Hidekatsu, et al.
Publicado: (2014)